Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study
2015 ◽
Vol 37
(6)
◽
pp. 366-368
◽
2002 ◽
Vol 75
(2)
◽
pp. 166-173
◽
2002 ◽
Vol 116
(1)
◽
pp. 87-93
◽
2003 ◽
Vol 78
(4)
◽
pp. 349-356
◽
2020 ◽
Vol 21
(3)
◽
pp. 1054
◽
2000 ◽
Vol 109
(3)
◽
pp. 622-628
◽